The US Senate confirmed Dr Stephen Hahn to be the next commissioner of the US Food and Drug Administration, Reuters reported.

Hahn is a radiation oncologist, who has been with the MD Anderson Cancer Center in Houston since 2015. Experts had highlighted his status as an outsider likely played a role in his nomination by President Donald Trump, the report said. The Senate voted 72 to 18 to confirm Hahn as commissioner. "Dr. Hahn can now get to work approving new life-saving drugs and devices, regulating tobacco and e-cigarettes, addressing the opioid crisis, ensuring pain patients can receive the medications they need and protecting our nation's food supply," Republican Sen. Lamar Alexander wrote in a Twitter post.
Hahn follows former FDA Commissioner Dr Scott Gottlieb, who stepped down in April and Dr Ned Sharpless, who served as acting FDA commissioner until November.